Bottom drawer stock. Just doesn't want to break out of this trading range. Very much based on fundamental valuation and no sentiment behind it at all.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
